 |
|
|
| |
DDW/2016: Ledipasvir/Sofosbuvir+/-Ribavirin in Patients Co-infected with HCV and HIV: Real-world Heterogeneous Population from the TRIO Network
- Academic and community treatment of a real-world, heterogeneous population
|
| |
| |
Reported by Jules Levin
DDW 2016 May 21-24 San Diego, CA
Kris Kowdley1, Bruce Bacon2, Michael Curry3, Douglas T. Dieterich4, Steven L. Flamm5, Lauren Guest6, Yoori Lee6, Naoky Tsai7, Zobair Younossi8, and Nezam Afdhal3
1Liver Care Network, Swedish Medical Center, 2Saint Louis University School of Medicine, 3Beth Israel Deaconess Medical Center, 4Icahn School of Medicine at Mount Sinai, 5Northwestern University Feinberg School of Medicine, 6Trio Health Analytics, 7Queens Medical Center, University of Hawaii, and 8Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital
|
| |
|
|
|
|
|
